American Society of Clinical Oncology

SHERPA: White

People

  1. Kris
    Kris
  2. Ladanyi
    Ladanyi
  3. Drilon
    Drilon
  4. Miller
    Miller
  5. Riely
    Riely
  6. Arcila
    Arcila
  7. Seshan
    Seshan
  8. Solit
    Solit
  9. Ginsberg
    Ginsberg
  10. Heelan
    Heelan

Groups

  1. Department of Medicine (8)
  2. GSK Faculty (8)
  3. Human Oncology and Pathogenesis Program (8)
  4. Solid Tumor Oncology Division (8)
  5. Thoracic Oncology (8)
  6. Tow Center for Developmental Oncology (TCDO) (6)
  7. Biostatistics Service (2)
  8. Body Imaging Service (2)
  9. Center for Pancreatic Cancer Research (2)
  10. Epidemiology and Biostatistics (2)
Search Within
  1. "Human Oncology and Pathogenesis Program"
  2. "Naiyer Rizvi"
Formats
  1. Meeting Abstract (7)
  2. Journal Article (1)
Groups
  1. Department of Medicine (8)
  2. GSK Faculty (8)
  3. Human Oncology and Pathogenesis Program (8)
  4. Solid Tumor Oncology Division (8)
  5. Thoracic Oncology (8)
  6. Tow Center for Developmental Oncology (TCDO) (6)

More Groups

People
  1. Naiyer Rizvi (8)
  2. Marc Ladanyi (6)
  3. Mark Kris (6)
  4. Alexander Drilon (4)
  5. Lu Wang (4)
  6. Gregory Riely (3)

More People

Years
  1. 2014 (2)
  2. 2013 (1)
  3. 2012 (1)
  4. 2009 (1)
  5. 2006 (1)
  6. 2005 (2)
Publications
  1. Journal of Clinical Oncology (8)

Results (8)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinicopathologic features of advanced RET fusion-positive lung cancers and outcomes in comparison to other fusion-positive lung cancers
    Meeting Abstract

    Drilon, A. E.; Hellmann, M. D.; Wang, L.; Cho, E. J.; Ladanyi, M.; Rizvi, N. A.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Next-generation sequencing (NGS) to identify actionable genomic alterations (GA) in "pan-negative" lung adenocarcinomas (ADC) from patients with no smoking or a light smoking (NS/LS) history
    Meeting Abstract

    Drilon, A. E.; Wang, L.; Arcila, M. E.; Cho, E. J.; Balasubramanian, S.; Greenbowe, J. R.; Ross, J. S.; Stephens, P.; Lipson, D.; Miller, V. A.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Screening for RET and ROS1 fusions in an enriched cohort of pan-negative never-smokers with advanced lung adenocarcinomas to identify patients for treatment in targeted therapy trials
    Meeting Abstract

    Drilon, A. E. D.; Wang, L.; Hasanovic, A.; Joubert, P.; Kris, M. G.; Riely, G. J.; Ladanyi, M.; Rizvi, N. A.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • KIF5B-RET: Discovery of a novel fusion oncogene in lung adenocarcinomas by a systematic screen for tyrosine kinase fusions and identification of patients for a RET targeted therapy trial
    Meeting Abstract

    Suehara, Y.; Arcila, M. E.; Drilon, A. E. D.; Ito, T.; Wang, L.; Hasanovic, A.; Khanin, R.; Rizvi, N. A.; Ladanyi, M.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Randomized phase II study of pulse erlotinib before or after carboplatin and paclitaxel in current or former smokers with advanced non-small-cell lung cancer
    Journal Article

    Riely, G. J.; Rizvi, N. A.; Kris, M. G.; Milton, D. T.; Solit, D. B.; Rosen, N.; Senturk, E.; Azzoli, C. G.; Brahmer, J. R.; Sirotnak, F. M.; more...
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Prospective trial with preoperative gefitinib to correlate lung cancer response with EGFR exon 19 and 21 mutations and to select patients for adjuvant therapy
    Meeting Abstract

    Kris, M. G.; Pao, W.; Zakowski, M. F.; Ladanyi, M.; Heelan, R. T.; Schwartz, L.; Zhao, B.; Venkatraman, E.; Rusch, V.; Rizvi, N. A.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Correlation of EGFR and KRAS mutation status, response to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors and survival with histologic subtypes of adenocarcinoma of the lung
    Meeting Abstract

    Hussain, S.; Zakowski, M. F.; Kris, M. G.; Ladanyi, M.; Pao, W.; Riely, G.; Rizvi, N.; Gomez, J. E.; Miller, V.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • A phase I dose escalation trial of pulsatile high dose gefitinib and docetaxel in patients with an advanced solid tumor
    Meeting Abstract

    Fury, M. G.; Kris, M.; Solit, D.; Pfister, D. G.; Azzoli, C. G.; Henry, R.; Su, Y. B.; Rizvi, N.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save